Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 267,145 | 157,172 | 138,012 | 95,321 | 166,826 |
| Marketable Securities | 94,460 | 19,048 | N/A | 10,433 | 49,728 |
| Receivables | 168,732 | 113,731 | 74,476 | 46,278 | N/A |
| Inventories | 62,165 | 40,885 | 49,821 | 32,907 | 2,314 |
| Income taxes - deferred | 19,643 | 16,726 | 972 | N/A | N/A |
| TOTAL | $646,556 | $373,456 | $277,101 | $204,417 | $236,776 |
| Non-Current Assets | |||||
| PPE Net | 162,240 | 164,691 | 139,885 | 104,280 | 39,135 |
| Intangibles | 44,100 | 48,543 | 52,279 | 20,891 | 19,954 |
| Other Non-Current Assets | 159,141 | 199,711 | 8,286 | 4,769 | 37,672 |
| TOTAL | $365,481 | $412,945 | $200,450 | $129,940 | $96,761 |
| Total Assets | $1,012,037 | $786,401 | $477,551 | $334,357 | $333,537 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,500 | N/A | N/A |
| Accounts payable and accrued liabilities | 16,026 | 11,530 | 33,655 | 9,072 | 10,939 |
| Accrued Expenses | 107,030 | 66,915 | 46,200 | 28,324 | 16,228 |
| Other current liabilities | 11,848 | 4,743 | N/A | N/A | N/A |
| TOTAL | $138,515 | $85,262 | $84,418 | $37,709 | $27,822 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,896 | 1,652 | 1,128 | 41 | 588 |
| Other Non-Current Liabilities | 13,042 | 12,076 | 145,023 | 194,593 | 176,000 |
| TOTAL | $13,786 | $12,783 | $146,132 | $195,092 | $181,038 |
| Total Liabilities | $152,301 | $98,045 | $230,550 | $232,801 | $208,860 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 182,617 | 178,275 | 163,391 | 152,427 | 142,964 |
| Common Shares | 18 | 5 | 5 | 4 | 4 |
| Retained earnings | -303,934 | -400,964 | -696,130 | -729,279 | -637,581 |
| Other shareholders' equity | -6,816 | -1,618 | 2,687 | -1,703 | -437 |
| TOTAL | $859,736 | $688,356 | $247,001 | $101,556 | $124,677 |
| Total Liabilities And Equity | $1,012,037 | $786,401 | $477,551 | $334,357 | $333,537 |